• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙的 SARS-CoV-2 早期传播归因于创始效应。

A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.

机构信息

AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain

IDIBAPS-Hospital Clinic de Barcelona, Barcelona, Spain.

出版信息

J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01583-20.

DOI:10.1128/JVI.01583-20
PMID:33127745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7925114/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whole-genome analysis has identified five large clades worldwide which emerged in 2019 (19A and 19B) and in 2020 (20A, 20B, and 20C). This study aimed to analyze the diffusion of SARS-CoV-2 in Spain using maximum-likelihood phylogenetic and Bayesian phylodynamic analyses. The most recent common ancestor (MRCA) of the SARS-CoV-2 pandemic was estimated to have emerged in Wuhan, China, around 24 November 2019. Phylogenetic analyses of the first 12,511 SARS-CoV-2 whole-genome sequences obtained worldwide, including 290 from 11 different regions of Spain, revealed 62 independent introductions of the virus in the country. Most sequences from Spain were distributed in clades characterized by a D614G substitution in the S gene (20A, 20B, and 20C) and an L84S substitution in ORF8 (19B) with 163 and 118 sequences, respectively, with the remaining sequences branching in 19A. A total of 110 (38%) sequences from Spain grouped in four different monophyletic clusters of clade 20A (20A-Sp1 and 20A-Sp2) and 19B clade (19B-Sp1 and 19B-Sp2) along with sequences from 29 countries worldwide. The MRCAs of clusters 19A-Sp1, 20A-Sp1, 19A-Sp2, and 20A-Sp2 were estimated to have occurred in Spain around 21 and 29 January and 6 and 17 February 2020, respectively. The prevalence of clade 19B in Spain (40%) was by far higher than in any other European country during the first weeks of the epidemic, probably as a result of a founder effect. However, this variant was replaced by G614-bearing viruses in April. assays showed an enhanced infectivity of pseudotyped virions displaying the G614 substitution compared with those having D614, suggesting a fitness advantage of D614G. Multiple SARS-CoV-2 introductions have been detected in Spain, and at least four resulted in the emergence of locally transmitted clusters that originated not later than mid-February, with further dissemination to many other countries around the world, and a few weeks before the explosion of COVID-19 cases detected in Spain during the first week of March. The majority of the earliest variants detected in Spain branched in the clade 19B (D614 viruses), which was the most prevalent clade during the first weeks of March, pointing to a founder effect. However, from mid-March to June 2020, G614-bearing viruses (clades 20A, 20B, and 20C) overcame D614 variants in Spain, probably as a consequence of an evolutionary advantage of this substitution in the spike protein. A higher infectivity of G614-bearing viruses than D614 variants was detected, suggesting that this substitution in SARS-CoV-2 spike protein could be behind the variant shift observed in Spain.

摘要

严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 全基因组分析已确定在全球范围内出现的五个大分支,分别于 2019 年(19A 和 19B)和 2020 年(20A、20B 和 20C)出现。本研究旨在利用最大似然系统发育和贝叶斯系统发育分析来分析 SARS-CoV-2 在西班牙的传播情况。SARS-CoV-2 大流行的最近共同祖先 (MRCA) 估计于 2019 年 11 月 24 日在中国武汉出现。对全球范围内获得的 12511 个 SARS-CoV-2 全基因组序列的首次分析,包括来自西班牙 11 个不同地区的 290 个序列,揭示了该病毒在该国的 62 次独立传入。西班牙的大多数序列分布在 S 基因中具有 D614G 取代的分支(20A、20B 和 20C)和 ORF8 中的 L84S 取代的分支(19B),分别有 163 和 118 个序列,其余序列分支在 19A 中。共有 110 个(38%)来自西班牙的序列分为四个不同的 20A 分支(20A-Sp1 和 20A-Sp2)和 19B 分支(19B-Sp1 和 19B-Sp2)聚类,以及来自全球 29 个国家的序列。19A-Sp1、20A-Sp1、19A-Sp2 和 20A-Sp2 聚类的 MRCA 分别估计于 2020 年 1 月 21 日和 29 日、2 月 6 日和 17 日在西班牙出现。西班牙 19B 分支的流行率(40%)在疫情初期明显高于任何其他欧洲国家,可能是由于创始效应。然而,这种变体在 4 月被携带 G614 的病毒取代。假型病毒感染试验表明,与具有 D614 的假型病毒相比,显示 G614 取代的假型病毒具有更高的感染性,这表明 D614G 具有适应性优势。已在西班牙检测到多次 SARS-CoV-2 传入,其中至少有 4 次导致当地传播的集群出现,其起源时间不晚于 2 月中旬,随后传播到全球许多其他国家,并在 3 月初西班牙首次发现 COVID-19 病例的前几周内。在西班牙检测到的最早的变异株中,大多数分支在 19B 分支(D614 病毒)中,这是 3 月初最流行的分支,表明存在创始效应。然而,从 3 月中旬到 2020 年 6 月,携带 G614 的病毒(20A、20B 和 20C 分支)在西班牙超过了携带 D614 的变体,这可能是由于 Spike 蛋白中的这种取代具有进化优势。与 D614 变体相比,携带 G614 的病毒的感染性更高,这表明 SARS-CoV-2 刺突蛋白中的这种取代可能是西班牙观察到的变体转变的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/6ada34511878/JVI.01583-20-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/86fb2efbe528/JVI.01583-20-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/586272bc5a3f/JVI.01583-20-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/ef22077650f8/JVI.01583-20-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/c76f5d845412/JVI.01583-20-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/2d06889f87c9/JVI.01583-20-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/aad6d6c3fbe2/JVI.01583-20-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/6ada34511878/JVI.01583-20-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/86fb2efbe528/JVI.01583-20-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/586272bc5a3f/JVI.01583-20-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/ef22077650f8/JVI.01583-20-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/c76f5d845412/JVI.01583-20-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/2d06889f87c9/JVI.01583-20-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/aad6d6c3fbe2/JVI.01583-20-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/7925114/6ada34511878/JVI.01583-20-f0007.jpg

相似文献

1
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.西班牙的 SARS-CoV-2 早期传播归因于创始效应。
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01583-20.
2
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.SARS-CoV-2 刺突蛋白 D614G 取代增加合胞体形成和病毒滴度通过增强的弗林蛋白酶介导的刺突裂解。
mBio. 2021 Aug 31;12(4):e0058721. doi: 10.1128/mBio.00587-21. Epub 2021 Jul 27.
3
Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan.全基因组测序揭示了 SARS-CoV-2 在巴基斯坦的 G614 变异株检测。
PLoS One. 2021 Mar 23;16(3):e0248371. doi: 10.1371/journal.pone.0248371. eCollection 2021.
4
The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.新型 SARS-CoV-2 在全球传播六个月后的分子变异程度。
Infect Genet Evol. 2021 Jul;91:104800. doi: 10.1016/j.meegid.2021.104800. Epub 2021 Mar 5.
5
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity.对印度新冠病毒基因组的分析揭示了刺突蛋白中D614G突变的流行情况,该突变预示着与跨膜丝氨酸蛋白酶2(TMPRSS2)的相互作用增加以及病毒传染性增强。
Front Microbiol. 2020 Nov 23;11:594928. doi: 10.3389/fmicb.2020.594928. eCollection 2020.
6
Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.新型冠状病毒刺突蛋白G614变体在冷藏后的稳定性超过D614变体。
mSphere. 2021 Mar 31;6(2):e00104-21. doi: 10.1128/mSphere.00104-21.
7
Phylogeography of SARS-CoV-2 pandemic in Spain: a story of multiple introductions, micro-geographic stratification, founder effects, and super-spreaders.西班牙 SARS-CoV-2 大流行的系统地理学分析:多重传入、微地理分层、奠基者效应和超级传播者的故事。
Zool Res. 2020 Nov 18;41(6):605-620. doi: 10.24272/j.issn.2095-8137.2020.217.
8
Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana.SARS-CoV-2 的基因组分析揭示了加纳的本地病毒进化。
Exp Biol Med (Maywood). 2021 Apr;246(8):960-970. doi: 10.1177/1535370220975351. Epub 2020 Dec 16.
9
Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.SARS-CoV-2 的分子进化:2019 年 12 月至 2022 年 8 月。
J Med Virol. 2023 Jan;95(1):e28366. doi: 10.1002/jmv.28366.
10
Evolutionary and Phylogenetic Dynamics of SARS-CoV-2 Variants: A Genetic Comparative Study of Taiyuan and Wuhan Cities of China.SARS-CoV-2 变异株的进化与系统发育动态:中国太原市与武汉市的遗传比较研究。
Viruses. 2024 Jun 3;16(6):907. doi: 10.3390/v16060907.

引用本文的文献

1
Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis.慢性淋巴细胞白血病患者中SARS-CoV-2疫苗接种的免疫反应动力学:一项描述性分析
Front Immunol. 2025 Jun 6;16:1571680. doi: 10.3389/fimmu.2025.1571680. eCollection 2025.
2
Early unrecognised SARS-CoV-2 introductions shaped the first pandemic wave, Sweden, 2020.2020 年,瑞典的早期未被识别的 SARS-CoV-2 传入,塑造了第一波大流行。
Euro Surveill. 2024 Oct;29(41). doi: 10.2807/1560-7917.ES.2024.29.41.2400021.
3
The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study.

本文引用的文献

1
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.追踪 SARS-CoV-2 刺突蛋白的变化:D614G 增加 COVID-19 病毒感染力的证据。
Cell. 2020 Aug 20;182(4):812-827.e19. doi: 10.1016/j.cell.2020.06.043. Epub 2020 Jul 3.
2
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.一种用于 SARS-CoV-2 谱系的动态命名建议,以辅助基因组流行病学研究。
Nat Microbiol. 2020 Nov;5(11):1403-1407. doi: 10.1038/s41564-020-0770-5. Epub 2020 Jul 15.
3
Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.
传统非甾体抗炎药和选择性 COX-2 抑制剂对 COVID-19 结局的作用:一项真实世界数据研究。
Inflammopharmacology. 2024 Dec;32(6):3697-3705. doi: 10.1007/s10787-024-01568-y. Epub 2024 Sep 23.
4
The molecular epidemiology of a dengue virus outbreak in Taiwan: population wide versus infrapopulation mutation analysis.台湾登革热病毒爆发的分子流行病学:全人群与亚人群突变分析。
PLoS Negl Trop Dis. 2024 Jun 13;18(6):e0012268. doi: 10.1371/journal.pntd.0012268. eCollection 2024 Jun.
5
Evolutionary trajectory of diverse SARS-CoV-2 variants at the beginning of COVID-19 outbreak.新冠疫情初期多种新冠病毒变异株的进化轨迹。
Virus Evol. 2024 Mar 5;10(1):veae020. doi: 10.1093/ve/veae020. eCollection 2024.
6
Genomic characterization of SARS-CoV-2 in Guinea, West Africa.西非几内亚地区的 SARS-CoV-2 基因组特征。
PLoS One. 2024 Mar 6;19(3):e0299082. doi: 10.1371/journal.pone.0299082. eCollection 2024.
7
Genomic characterisation of respiratory syncytial virus: a novel system for whole genome sequencing and full-length G and F gene sequences.呼吸道合胞病毒的基因组特征:一种新的全基因组测序和全长 G 和 F 基因序列系统。
Euro Surveill. 2023 Dec;28(49). doi: 10.2807/1560-7917.ES.2023.28.49.2300637.
8
Genomic surveillance of SARS-CoV-2 in Weihai, China, march 2022 to march 2023.2022 年 3 月至 2023 年 3 月在中国威海对 SARS-CoV-2 的基因组监测。
Front Public Health. 2023 Nov 14;11:1273443. doi: 10.3389/fpubh.2023.1273443. eCollection 2023.
9
Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19.接受完整COVID-19疫苗接种方案的慢性髓性白血病患者的常规体液免疫和细胞免疫反应
Cancers (Basel). 2023 Oct 20;15(20):5066. doi: 10.3390/cancers15205066.
10
Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination.接种疫苗后接受自体或异基因干细胞移植的肿瘤血液疾病患者对SARS-CoV-2的持久免疫力。
Cancers (Basel). 2023 Apr 18;15(8):2344. doi: 10.3390/cancers15082344.
德国一起旅行相关原发性病例引发的 COVID-19 暴发调查:病例系列研究。
Lancet Infect Dis. 2020 Aug;20(8):920-928. doi: 10.1016/S1473-3099(20)30314-5. Epub 2020 May 15.
4
A Novel Bat Coronavirus Closely Related to SARS-CoV-2 Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein.一种新型蝙蝠冠状病毒与 SARS-CoV-2 密切相关,其 Spike 蛋白 S1/S2 裂解位点存在天然插入。
Curr Biol. 2020 Jun 8;30(11):2196-2203.e3. doi: 10.1016/j.cub.2020.05.023. Epub 2020 May 11.
5
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?穿山甲是否是 2019 新型冠状病毒(SARS-CoV-2)的中间宿主?
PLoS Pathog. 2020 May 14;16(5):e1008421. doi: 10.1371/journal.ppat.1008421. eCollection 2020 May.
6
The proximal origin of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的近端起源。
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
7
Preliminary case report on the SARS-CoV-2 cluster in the UK, France, and Spain.英国、法国和西班牙的 SARS-CoV-2 集群初步病例报告。
Swiss Med Wkly. 2020 Feb 27;150:w20212. doi: 10.4414/smw.2020.20212. eCollection 2020 Feb 24.
8
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.SARS-CoV-2 刺突糖蛋白的特征及其对病毒进入的影响,以及与 SARS-CoV 的免疫交叉反应性。
Nat Commun. 2020 Mar 27;11(1):1620. doi: 10.1038/s41467-020-15562-9.
9
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins.鉴定马来穿山甲体内的 SARS-CoV-2 相关冠状病毒
Nature. 2020 Jul;583(7815):282-285. doi: 10.1038/s41586-020-2169-0. Epub 2020 Mar 26.
10
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒:将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.